Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
Public ClinicalTrials.gov record NCT01177410. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Placebo-controlled, Double-blind, Multicenter, 12 Week Study to Assess the Efficacy and Safety of Mesalamine Granules 750 mg and 1,500 mg Capsules Administered Once Daily in the Treatment of Irritable Bowel Syndrome With Diarrhea
Study identification
- NCT ID
- NCT01177410
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bausch Health Americas, Inc.
- Industry
- Enrollment
- 148 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Mesalamine Granules 750 mg Drug
- Mesalamine Granules 1500 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2010
- Primary completion
- Jul 31, 2011
- Completion
- Jul 31, 2011
- Last update posted
- Nov 20, 2019
2010 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Sherwood | Arkansas | 72120 | — |
| Not listed | Anaheim | California | 92801 | — |
| Not listed | Sacramento | California | 95831 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Bristol | Connecticut | 06010 | — |
| Not listed | Boynton Beach | Florida | 33426 | — |
| Not listed | St. Petersburg | Florida | 33709 | — |
| Not listed | Macon | Georgia | 31201 | — |
| Not listed | Shreveport | Louisiana | 71103 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Wyoming | Michigan | 49519 | — |
| Not listed | Mexico | Missouri | 65265 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Albuquerque | New Mexico | 87102 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Greensboro | North Carolina | 27408 | — |
| Not listed | Plano | Texas | 75075 | — |
| Not listed | Ogden | Utah | 84405 | — |
| Not listed | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01177410, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01177410 live on ClinicalTrials.gov.